| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |